Evaluation of Myocardial Perfusion and Left Ventricular Function Six Months after Percutaneous Transmyocardial Laser Revascularization: Comparison of Two Ho-YAG Laser Systems with the Same Wavelength, but Different Energy Delivery and Navigation Systems

Lasers in Surgery and Medicine

Volumn 33, Issue 5, 2003, Pages 273-281

  Strehblow, Christoph ^a   Gyöngyösi, Mariann ^a   Khorsand, Aliasghar ^a   Sperker, Wolfgang ^a   Gatterer, Melanie ^a   Graf, Senta ^a   Sochor, Heinz ^a   Glogar, Dietmar ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Biosense DMR; Eclipse laser; Myocardial perfusion; Myocardial viability; NOGA endocardial mapping; PTMR

Indexed keywords

THALLIUM 201;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; CLINICAL ARTICLE; CORONARY ARTERY DISEASE; ENDOCARDIAL MAPPING; ENDOCARDIUM; ENERGY; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE PERFUSION; HEART MUSCLE REVASCULARIZATION; HEART SCINTISCANNING; HEART VENTRICULOGRAPHY; HOLMIUM LASER; HUMAN; INTERMETHOD COMPARISON; LASER SURGERY; MALE; PERCUTANEOUS TRANSMYOCARDIAL LASER REVASCULARIZATION; PRIORITY JOURNAL; TISSUE DISTRIBUTION; TREATMENT OUTCOME;

AGED; BODY SURFACE POTENTIAL MAPPING; CORONARY ARTERIOSCLEROSIS; CORONARY CIRCULATION; EXERCISE TOLERANCE; FEMALE; FOLLOW-UP STUDIES; HEART; HUMANS; LASER SURGERY; MALE; MIDDLE AGED; MYOCARDIAL REPERFUSION; MYOCARDIAL REVASCULARIZATION; RADIATION; STEREOTAXIC TECHNIQUES; SURVIVAL ANALYSIS; VENTRICULAR FUNCTION, LEFT;

EID: 0348141748     PISSN: 01968092     EISSN: None     Source Type: Journal    
DOI: 10.1002/lsm.10230     Document Type: Article

References (34)

1. Mirhoseini M, Cayton MM, Shelgikar S. Clinical report: Laser myocardial revascularization. Lasers Surg Med 1986;6:459-461.
2. Frazier OH, Cooley DA, Kadipasaoglu KA. Myocardial revascularization with laser-Preliminary findings. Circulation 1995;92(Suppl II):II-58-II-65.
3. Cooley DA, Frazier OH, Kadipasaoglu KA. Transmyocardial laser revascularization: Clinical experience with twelve month follow-up. J Thorac Cardiovasc Surg 1996;111:791-799.
4. Horvath KA, Cohn LH, Cooley D. Transmyocardial laser revascularization: Results of a multicenter trial with transmyocardial laser revascularization used as sole therapy for end-stage coronary artery disease. J Thorac Cardiovasc Surg 1997;113:645-654.
5. Mirhoseini M, Cayton MM. Revascularization of the heart by laser. J Microsurg 1981;2:253-260.
6. Gassler N, Wintzer HO, Stubbe HM. Transmyocardial laser revascularization: Histologic features in human nonresponder myocardium. Circulation 1997;95:371-375.
7. Krabatsch T, Schaper F, Tambeur L. Histomorphology after transmyocardial revascularization. Herz 1997;22:205-210.
8. Whittaker P. Transmyocardial revascularization: The fate of myocardial channels. Ann Thorac Surg 1999;68(6):2376-2382.
9. Whittaker P, Spariosu K, Ho ZZ. Success of transmyocardial laser revascularization is determined by the amount and organization of scar tissue produced in response to initial injury: Results of ultraviolet laser treatment. Lasers Surg Med 1999;24(4):253-260.
10. Hughes GC, Lowe JE, Kypson AP. Neovascularization after transmyocardial laser revascularization in a model of chronic ischemia. Ann Thorac Surg 1998;66:2029-2036.
11. 2 laser. Ann Thorac Surg 1997;63:1275-1283.
12. van der Sloot JA, Huikeshoven M, van der Wal AC, Tukkie R, van Gemert MJ, van der Meulen J, Beek JF. Angiogenesis three months after clinical transmyocardial laser revascularization using an excimer laser. Lasers Surg Med 2001;29(4): 369-373.
13. Hughes GC, Landolfo KP, Lowe JE. Perioperative morbidity and mortality after transmyocardial laser revascularization: Incidence and risk factors for adverse events. J Am Coll Cardiol 1999;33:1021-1026.
14. Frazier OH, March RJ, Horvath KA. Transmyocardial revascularization with a carbon dioxide laser in patients with end-stage coronary artery disease. N Engl J Med 1999;341:1021-1028.
15. Allen KB, Dowling RD, Fudge TL. Comparison of transmyocardial revascularization with medial therapy in patients with refractory angina. N Engl J Med 1999;341:1029-1036.
16. Schofield PM, Sharples LD, Caine N. Transmyocardial laser revascularization in patients with refractory angina: A randomised controlled trial. Lancet 1999;353:519-524.
17. Nägele H, Stubbe HM, Nienaber C. Results of transmyocardial laser revascularization in non-revascularizable coronary artery disease after 3 years follow-up. Eur Heart J 1998;19(10):1525-1530.
18. Agarwal R, Ajit M, Kurian VM. Transmyocardial laser revascularization: Early results and 1-year follow-up. Ann Thorac Surg 1999;67:432-436.
19. Oesterle SN, Sanborn TA, Ali N. Percutaneous transmyocardial laser revascularization for severe angina: The PACIFIC randomised trial. Potential class improvement from intramyocardial channels. Lancet 2000;356(9243): 1705-1710.
20. Kornowski R, Baim DS, Moses JW. Short- and intermediate-term clinical outcomes from direct myocardial laser revascularization guided by biosense left ventricular electromechanical mapping. Circulation 2000;102:1120.
21. Ben-Haim SA, Osadchy D, Schuster I. Nonfluoroscopic, in vivo navigation and mapping technology. Nat Med 1996;2:1393-1395.
22. Gepstein L, Hayam G, Ben-Haim SA. A novel method for nonfluoroscopic catheter-based electroanatomical mapping of the heart: In vitro and in vivo accuracy results. Circulation 1997;95:1611-1622.
23. Gepstein L, Hayam G, Shpun S. Hemodynamic evaluation of the heart with a nonfluoroscopic electromechanical mapping technique. Circulation 1997;96:3672-3680.
24. Gyöngyösi M, Sochor H, Khorsand A. Online myocardial viability assessment in the catheterization laboratory via NOGA electroanatomic mapping-Quantitative comparison with thallium-201 uptake. Circulation 2001;104:1005-1011.
25. Lehmkuhl H, Altstidl R, Machnig T. On-line evalution of systolic performance by densitometry in digital left ventriculography. Clin Cardiol 1996;19(9):729-736.
26. Faraggi M, Montalescot G, Sarda L, Heintz JF, Doumit D, Drobinski G, Sotirov I, Le Guludec D, Thomas D. Spontaneous late improvement of myocardial viability in the chronic infarct zone is possible, depending on persistent TIMI 3 flow and a low grade stenosis of the infarct artery. Heart 1999;81(4):424-430.
27. Bienenfeld L, Frishman W, Glasser SP. The placebo effect in cardiovascular disease. Am Heart J 1996;132(6):1207-1221.
28. Moerman DE, Jonas WB. Deconstructing the placebo effect and finding the meaning response. Ann Intern Med 2002;136(6):471-476.
29. Dowling RD, Petracek MR, Selinger SL. Transmyocardial revascularization in patients with refractory, unstable angina. Circulation 1998;198:11-73-11-76.
30. Burns SM, Sharples LD, Tait S. The transmyocardial laser revascularization - International registry report. Eur Heart J 1999;20:31-37.
31. Milano A, Pratali S, Tartarini G. Early results of transmyocardial revascularization with a holmium laser. Ann Thorac Surg 1998;65:700-704.
32. Horvath KA, Smith WJ, Laurence RG. Recovery and viability of an acute myocardial infarct after transmyocardial laser revascularization. J Am Coll Cardiol 1995;25:258-263.
33. Donovan CL, Landolfo KP, Lowe JE. Improvements in inducible ischemia during dobutamine stress echocardiography after transmyocardial laser revascularization in patients with refractory angina pectoris. J Am Coll Cardiol 1997;30(3): 607-612.
34. Nägele H, Kalmar P, Löbeck M. Transmyocardial laser revascularization - Treatment option for coronary artery disease? Ger J Cardiol 1997;86:171-178.